Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-003006

Director sold 5,000 shares at an average $56.30 ($281,517)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Henderson Jeffrey William Director 2025-02-03 Sale 10b5-1 −1,100 $55.94 $61,537 42,511 D: show line 1 in the form
Henderson Jeffrey William Director 2025-02-03 Sale 10b5-1 −3,900 $56.41 $219,980 38,611 D: show line 2 in the form
Open-market sales · 5,000 sh · avg $56.30 · $281,517
Loading xslF345X05/form4-02042025_110227.xml…